Stay updated on Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.

Latest updates to the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA newer revision entry (v3.6.3) was added to the record history and an older revision (v3.6.0) was removed, updating the history to reflect the latest version.SummaryDifference0.1%

- Check36 days agoChange DetectedThe study record shows recruitment has closed to new participants and the record has been revised to version v3.6.0, replacing the prior v3.5.5 label.SummaryDifference0.4%

- Check43 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a minor update to the study history page.SummaryDifference0.1%

- Check65 days agoChange DetectedThe bottom revision stamp updates from v3.5.3 to v3.5.4, reflecting a new revision of the record history. This indicates the study record has been updated.SummaryDifference0.1%

- Check86 days agoChange DetectedUpdated the ClinicalTrials.gov interface/revision label from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy Selinexor Pembrolizumab Combo in Melanoma Clinical Trial page.